insights_auto
Hvorfor er CMXHF faldet med 3,91%?
Dyk dybere nedchevron_right
CMXHF:OTCMKTS
CSL
121,10Â US$
arrow_downward
-3,91%(-4,93) 1D
9. okt., 16.00.00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for CMXHF...
Ã…bn
121,10Â US$
Høj
121,10Â US$
Lav
121,10Â US$
Markedsværdi
88,22Â mia.
Gns. vol.
151,00
Volumen
479,00
Højeste i 52 uger
148,36Â US$
Laveste i 52 uger
63,84Â US$
Beta
0,56
Aktier i omløb
479,88Â mio.
Antal ansatte
29Â t
Ã…bn
121,10Â US$
Høj
121,10Â US$
Lav
121,10Â US$
Markedsværdi
88,22Â mia.
Gns. vol.
151,00
Volumen
479,00
Højeste i 52 uger
148,36Â US$
Laveste i 52 uger
63,84Â US$
Beta
0,56
Aktier i omløb
479,88Â mio.
Antal ansatte
29Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Pluang
·
for 2 dage siden
Haemonetics shares rise 13% as CSL plans 2027 r...
Yahoo Finance
·
for 2 dage siden
Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers
Investing.com
·
for 2 dage siden
Haemonetics stock surges 17% on CSL Plasma supply deal update
GuruFocus
·
for 2 dage siden
Haemonetics (HAE) Shares Jump 14% Premarket on CSL Supply Agreem
Profil
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Om CSL
Administrerende direktørPaul McKenzie
Ansatte29Â t
Grundlagt1916
HovedsædeMelbourne, Victoria, Australien
Sektor-
Websitecsl.com